Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c2453 |
|---|---|
| Identifier | NCT03466411 |
| Trial Title | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Guselkumab Dose 1|DRUG: Guselkumab Dose 2|DRUG: Guselkumab Dose 3|DRUG: Guselkumab Dose 4|DRUG: Guselkumab Dose 5|DRUG: Guselkumab|DRUG: Ustekinumab|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2018-04-13 |
|---|---|
| Primary Completion Date | 2023-10-20 |
| Completion Date | 2028-01-28 |